MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ITCI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intra-Cellular Therapies (ITCI) Ownership - Who owns Intra-Cellular Therapies?

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
430 East 29th Street
Phone
+1 646 440-9333
Employees
610
Web
https://www.intracellulartherapies.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
6.7B
P/E Ratio
N/A
Total Cash
497.94M
Projected Growth
N/A
Total Debt
16.94M
Revenue
462.18M
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash/Share
5.14
Total Debt/Equity
N/A
Revenue/Share
4.82 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ITCI
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Details
Industry
Biotechnology
Address
430 East 29th Street
Phone
+1 646 440-9333
Employees
610
Web
https://www.intracellulartherapies.com